loading...| Preferred Name | Rituximab | |
| Synonyms |
|
|
| ID |
http://www.phoc.org.cn/pmo/class/PMO_00022034 |
|
| Database_Cross_Reference |
NCI_FDA:4F4X42SYQ6 RCD:hh1.. NDDF:007236 LNC:MTHU054566 PDQ:CDR0000042613 CSP:1554-5053 MTH:NOCODE MTHSPL:4F4X42SYQ6 MMSL:d04255 VANDF:4021104 RXNORM:121191 SNOMEDCT_US:386919002 CHV:0000032196 MMSL:5432 NDFRT:N0000005430 DRUGBANK:DB00073 NCI:TCGA SNOMEDCT_US:108809004 CSP:0220-6201 USPMG:MTHU002535 NCI_NCI-GLOSS:CDR0000045525 NCI:C1702 MSH:D000069283 ATC:L01XC02 NDFRT:N0000148560 MEDCIN:197510 LNC:LP220253-1 |
|
| label |
Rituximab |
|
| MCID |
MC00139479 |
|
| PMOID |
PMO:00022034 |
|
| prefixIRI |
pmo:PMO_00022034 |
|
| prefLabel |
Rituximab |
|
| Synonym |
anti-CD20 monoclonal antibody Rituximab [Chemical/Ingredient] riTUXimab RITUXIMAB rituximab (medication) Rituxan Hycela Chimeric Anti-CD20 Antibody Rituxan Sc Rituximab CD20 Antibody monoclonal antibody anti-CD20 C2B8 Monoclonal Antibody CD20 Antibody, Rituximab Ig gamma-1 chain C region AntiCD20 rituximab Rituximab (product) Antibody, Rituximab CD20 Rituximab (substance) |
|
| Tree Number |
T6.4.2.1.2.6.8.3.1 T6.8.1.84.16.2.6.8.3.1 T6.8.1.84.12.6.6.8.3.1 T6.8.1.72.4.6.6.8.3.1 |
|
| subClassOf |